Skip to content

Advertisement

Open Access

Discussion session: biomarker trials

  • Various speakers
Trials201516(Suppl 2):I2

https://doi.org/10.1186/1745-6215-16-S2-I2

Published: 16 November 2015

Keywords

Public HealthTrial DesignDiscussion SessionCombine Presentation

Various speakers In a combined presentation and discussion session, representatives from academia and industry discuss the role of Biomarker trial design and implementation, to improve health by improving trials.

Copyright

© Various speakers 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement